Skip to content
★ Sign in to follow
MS

Melita Sun Jung

Executive
Terns Pharmaceuticals, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€11k
▼ Sales (0 ops.)
—

Latest filing published 03 Feb 2025 for Terns Pharmaceuticals, Inc., €11k.

Filing timeline

BuySale
Melita Sun Jung

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Melita Sun Jung: trading record in brief

Our data holds just one disclosure by Melita Sun Jung, dated 3 February 2025, reporting an open-market purchase worth €11k in Terns Pharmaceuticals, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Melita Sun Jung

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Business OfficerExecutivesTerns Pharmaceuticals, Inc.
    11,498 USD31SEC
    2,250 shares@ US$5.11100.0% of flowCommon StockSEC:0001562180-25-000853:0
    Canonical exit: 28 Feb 2025 (T+90)

1 of 1 declaration